We have pharmaceutical companies that are constantly trying to expand the indications, expand the number of people who are eligible for a given treatment, because that obviously helps their bottom line. We have advocacy groups, like the one that's come up with pre-vivor, who want to make more and more people feel they are at risk, or might have a condition, so that they can raise more funds and raise visibility, et cetera.
我们有些制药公司一直在试图扩大用药指征， 好让更多的人有理由接受它的治疗。 因为这样明显会有利于他们盈利。我们有一些宣传组织， 就像刚刚那个想出来前存者的组织， 他们想让越来越多的人觉得自己有高发因素，或是有症状， 好让他们募得更多的资金， 或是提高知名度或获取其他利益。